Stem Cell Therapy Market: By Treatment (Allogeneic, Autologous), By Cell Type (Adult Stem Cells, Induced Pluripotent Stem Cells, Human Embryonic Stem Cells, Others), By Technology (Cell Production, Cell Acquisition, Cryopreservation), By End-User (Hospitals, Ambulatory Surgical Centers, Research Centers) and Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Stem Cell Therapy Market size was valued at USD 16.5 billion in 2022 and is expected to reach USD 32.2 billion by 2029, at a CAGR of 10% from 2023-2029 Stem cell therapy involves use of stem cells to treat various diseases or disorders. Stem cells are fundamental for every organ and tissue in the body. Stem cells are indistinguishable biological cells that are able to differentiate into specialised cells (liver cells, cardiac cells etc.) and can renew itself (through mitosis) to produce more stem cells. Stem cells have the ability to replicate, repair, and replace other damaged tissues in the human body. In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others. Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. 

Stem Cell Therapy Market Key Developments:
  • For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDI's induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. 
  • Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership with Be The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.

Global Stem Cell Therapy Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

10%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Stem Cell Therapy Market Dynamics

Growing awareness about the potency of stem cells in disease management, development of advanced gene based analysis techniques and increase in public, private investments in stem cell research are acting as growth drivers for stem cell therapy market. In addition, identification of new stem cell lines and development of infrastructure for stem cell banking & processing are propelling the growth of the global stem cell therapy market. However, ethical issues involved in stem cells research such as destruction of human embryos, religious beliefs are considered as road blocks for adaptation of stem cell therapy by patients. However, stringent regulations to conduct trials on humans, high-cost of research and storage of stem cells are some restraining factors for stem cell therapy market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Stem Cell Therapy Market Segmentation

By Treatment
  • Allogeneic
  • Autologous
By Cell Type
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Human Embryonic Stem Cells
  • Others
By Technology
  • Cell Production
  • Cell Acquisition
  • Cryopreservation
By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Research Centers

Frequently Asked Questions

Asia-Pacific is growing at the highest CAGR over 2023- 2029.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive summary
  2. Global Stem Cell Therapy Market Introduction
    • Global Stem Cell Therapy Market“ Taxonomy
    • Global Stem Cell Therapy Market“Definitions
      • Treatment Type
      • Cell Type
  1. Global Stem Cell Therapy Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Stem Cell Therapy Market Dynamics Factors Impact Analysis
    • Global Stem Cell Therapy Market Regulations
      • US
      • Europe
      • Japan
  1. Global Stem Cell Therapy Market Analysis, 2018-2022 and Forecast 2023-2029
    • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Oppurtunity Analysis
  2. Global Stem Cell Therapy Market, By Treatment Type, 2018-2022 and Forecast 2023-2029
    • Allogeneic
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Autologous
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Stem Cell Therapy Market Forecast, By Cell Type, 2018-2022 and Forecast 2023-2029
    • Adult Stem Cells
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Induced Pluripotent Stem Cells
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Human Embryonic Stem Cells
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Stem Cell Therapy Market Forecast, By End User, 2018-2022 and Forecast 2023-2029
    • Hospitals
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Surgical Centers
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Research Centers
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Stem Cell Therapy Market Forecast, By Region, 2018-2022 and Forecast 2023-2029
    • North America
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018-2022 and Forecast 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Stem Cell Therapy Market- Opportunity Analysis Index - By Treatment Type, By Cell Type, By End User, and Region, 2023-2029
  2. North America Stem Cell Therapy Market Analysis, 2018-2022 and Forecast 2023-2029
    • Treatment Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Stem Cell Therapy Market- Opportunity Analysis Index - By Treatment Type, By Cell Type, By Technology, By End User, and Country, 2023-2029
    • North America Stem Cell Therapy Market Dynamics “ Trends
  3. Europe Stem Cell Therapy Market Analysis, 2018-2022 and Forecast 2023-2029
    • Treatment Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Stem Cell Therapy Market- Opportunity Analysis Index - By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2023-2029
    • Europe Stem Cell Therapy Market Dynamics “ Trends
  4. Asia-Pacific Stem Cell Therapy Market Analysis, 2018-2022 and Forecast 2023-2029
    • Treatment Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn),
  5. Y-o-Y Growth (%), and Market Share (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Asia-Pacific Stem Cell Therapy Market- Opportunity Analysis Index - By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2023-2029
  • Asia-Pacific Stem Cell Therapy Market Dynamics “ Trends
  1. Latin America Stem Cell Therapy Market Analysis, 2018-2022 and Forecast 2023-2029
    • Treatment Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Stem Cell Therapy Market- Opportunity Analysis Index - By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2023-2029
    • Latin America Stem Cell Therapy Market Dynamics “ Trends
  2. Middle East & Africa Stem Cell Therapy Market Analysis, 2018-2022 and Forecast 2023-2029
    • Treatment Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2018-2022)and Forecast (2023-2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Stem Cell Therapy Market- Opportunity Analysis Index - By Treatment Type, By Cell Type, By Technology, By End User, and Country, 2023-2029
    • MEA Stem Cell Therapy Market Dynamics “ Trends
  3. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Cytori Therapeutics Inc. (U.S.)
      • Fibrocell Science (U.S.)
      • Cellartis AB (Cellectis) (France)
      • BioTime, Inc. (U.S.)
      • GE Healthcare (U.S.)
      • Thermo Fisher Scientific (U.S.)
      • STEMCELL Technologies Inc. (Canada)
      • Fujifilm Holdings Corporation (Japan)
      • Vericel Corporation (Aastrom Bioscience) (U.S.)
      • Brainstorm cell therapeutics (U.S.)
      • Osiris Therapeutics, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Cytori Therapeutics Inc. (U.S.)
  • Fibrocell Science (U.S.)
  • Cellartis AB (Cellectis) (France)
  • BioTime, Inc. (U.S.)
  • GE Healthcare (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • STEMCELL Technologies Inc. (Canada)
  • Fujifilm Holdings Corporation (Japan)
  • Vericel Corporation (Aastrom Bioscience) (U.S.)
  • Brainstorm cell therapeutics (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Stryker Corporation (U.S.)
  • Celgene Corporation (U.S.)
  • Osiris Therapeutics, Inc. (U.S.)

Adjacent Markets